Cancer information Built for Asia
Ask anything about cancer. Our AI reads your records, diagnosis, treatments, side effects, costs and clinical-trial options.
Created by survivors and caregivers, with guidance shaped by oncologist input.
CancerAsia.AI supports your care team — it doesn't replace it.
Why use usA general AI has never seen your scan, your country, or your options. We read all three.
“Invasive ductal carcinoma, pT2N1M0, ER+/PR+/HER2-, Ki-67 18%, margins negative.”
This describes Stage IIA hormone-receptor-positive breast cancer. The report says the surgical margins are clear. Your doctor can explain how these findings affect treatment recommendations and outlook.
Resource guides built for you
Browse clear guides on cancer types, treatments, side effects, caregiving and life beyond treatment.
Built from lived experience
CancerAsia.AI was created by people with lived experience of cancer and caregiving, alongside backgrounds in technology, healthcare and media. With oncologist partners and advisors, we're building more accessible cancer information for people across Asia.